Abstract

Background

End colostomy rates following colorectal resection vary across institutions in high-income settings, being influenced by patient, disease, surgeon and system factors. This study aimed to assess global variation in end colostomy rates after left-sided colorectal resection.

Methods

This study comprised an analysis of GlobalSurg-1 and -2 international, prospective, observational cohort studies (2014, 2016), including consecutive adult patients undergoing elective or emergency left-sided colorectal resection within discrete 2-week windows. Countries were grouped into high-, middle- and low-income tertiles according to the United Nations Human Development Index (HDI). Factors associated with colostomy formation versus primary anastomosis were explored using a multilevel, multivariable logistic regression model.

Results

In total, 1635 patients from 242 hospitals in 57 countries undergoing left-sided colorectal resection were included: 113 (6·9 per cent) from low-HDI, 254 (15·5 per cent) from middle-HDI and 1268 (77·6 per cent) from high-HDI countries. There was a higher proportion of patients with perforated disease (57·5, 40·9 and 35·4 per cent; P < 0·001) and subsequent use of end colostomy (52·2, 24·8 and 18·9 per cent; P < 0·001) in low- compared with middle- and high-HDI settings. The association with colostomy use in low-HDI settings persisted (odds ratio (OR) 3·20, 95 per cent c.i. 1·35 to 7·57; P = 0·008) after risk adjustment for malignant disease (OR 2·34, 1·65 to 3·32; P < 0·001), emergency surgery (OR 4·08, 2·73 to 6·10; P < 0·001), time to operation at least 48 h (OR 1·99, 1·28 to 3·09; P = 0·002) and disease perforation (OR 4·00, 2·81 to 5·69; P < 0·001).

Conclusion

Global differences existed in the proportion of patients receiving end stomas after left-sided colorectal resection based on income, which went beyond case mix alone.

This secondary analysis of an international prospective multicentre observational study demonstrates significant variation in the proportion of patients receiving an end stoma after left-sided colorectal resection between high- and low–middle-income countries; this cannot be accounted for by case mix alone. This could relate to unmeasured patient risk characteristics, but may also reflect delayed access to surgical care, lack of equipment for anastomosis formation, or differences in subspecialist colorectal training.

Wide variation in stoma rates

Introduction

In 2015, the Lancet Commission on Global Surgery highlighted a substantial gap in access to safe and affordable surgical care across low- and middle-income countries (LMICs), raising the priority of surgery on the global health agenda1. Despite this, reporting of outcomes following abdominal surgery from many LMICs remains unstandardized and of mixed quality. Where high-quality evidence is available, a threefold higher risk of death in low- versus high-income settings has been observed2. However, other key outcomes from the surgical management of colorectal cancer or benign colorectal disease in LMICs have been particularly poorly profiled to date3.

End colostomy rates following colorectal cancer resection vary substantially between centres in high-income countries, ranging from 15 to 70 per cent4. This may reflect variations in case mix, as the decision to create an end colostomy rather than a primary restorative anastomosis is influenced by the urgency of presentation, the presence of operative field contamination, disease severity and stage, as well as functional status of the pelvic floor. For patients, quality of life with an end colostomy is influenced by multiple factors, including functional status, social support, income level, education and availability of specialist services5. The care requirements of a stoma may present a different psychosocial and physiological burden for patients in LMICs compared with those in high-income settings. For example, geographical barriers and limited health resources are likely to raise treatment costs and reduce access to specialist equipment and services6, increasing the risk of catastrophic expenditure following colorectal surgery7. Examining international practice in stoma formation is therefore important in seeking to identify areas of variation and improve outcomes.

The primary aim of this study was to determine variation in rates of end colostomy formation following colorectal resection between low-, middle- and high-Human Development Index (HDI) strata, after adjusting for patient, disease and operative factors. Secondary aims were to report the mode of presentation, rate of laparoscopic surgery, and to determine any relationship between stoma formation and postoperative mortality in patients undergoing resections.

Methods

Protocol and network

This study was an exploratory subgroup analysis from two international, multicentre, prospective cohort studies conducted according to previously published protocols (NCT02179112, NCT02662231)2,8. These protocols were disseminated through social media, and national and international surgical and anaesthetic associations. Briefly, the model required small teams of local investigators to collect data on prospectively determined items, coordinated by regional and national lead investigators, across short time windows, with pooled analysis by a central steering committee.

Patients and settings

Any hospital providing both emergency surgery and elective colorectal surgical services was eligible to contribute patients to this study. Patients were included during at least one discrete 2-week period between 1 July 2014 and 31 December 2014 (GlobalSurg-1) and 4 January 2016 and 31 July 2016 (GlobalSurg-2). To maximize inclusiveness and minimize burden on resource-constrained clinicians, collaborators were permitted to collect data within any 2-week interval across this time window, so long as data collection was consecutive and case ascertainment was complete. Adult patients (aged over 16 years) undergoing elective (GlobalSurg-2) or emergency (GlobalSurg-1 and -2) left hemicolectomy, sigmoid colectomy or rectal resection were included. Emergency procedures were defined as unplanned operations occurring within 2 weeks of hospital admission, and included procedures for trauma and reoperation following surgical complications. Open, laparoscopic and laparoscopic converted to open procedures were all eligible. To reduce risk of bias based on case mix, only colorectal resections for a primary gastrointestinal indication were included. Patients were excluded if the primary indication for surgery was vascular, gynaecological, obstetric, urological or transplantation, or if they were undergoing multivisceral resection.

Ethics and reporting

A UK National Health Service (NHS) Research Ethics review considered both studies exempt from formal research registration (South East Scotland Research Ethics Service, references NR/1404AB12 and NR/1510AB5). Individual centres were responsible for audit or institutional review board or ethical approval if required by local regulations. This study is reported according to the STROBE guidelines9.

Outcome measures

The primary outcome measure was the end colostomy formation rate, defined as formation of an end colostomy during the index procedure without restorative anastomosis. The secondary outcome measure was the postoperative mortality rate (death within 30 days of the index procedure).

Other included explanatory variables

Data variables were designed to be assessed objectively, standardizable and internationally relevant. Variables deemed candidates in the causal pathway for stoma formation were indication for surgery, urgency of surgery (elective/planned or emergency/unplanned (within 2 weeks of hospital admission)) and colonic or rectal perforation noted at the time of surgery. Variables deemed to be confounders associated with both the causal pathway and outcome measures included age, sex, ASA fitness classification, smoking status, use of the WHO Surgical Safety checklist10, and use of laparoscopic surgery.

Data capture and validation

Study data were collected and managed using REDCap (Research Electronic Data Capture) tools hosted at the University of Edinburgh (https://www.project-redcap.org/). REDCap is a secure, web-based application designed to support data capture for research studies, providing: an intuitive interface for validated data entry; audit trails for tracking data manipulation and export procedures; automated export procedures for seamless data downloads to common statistical packages; and procedures for importing data from external sources. In both studies, a local lead investigator was responsible for overall quality assurance, case ascertainment and data accuracy at each centre. Where missing data were identified, the lead investigator was contacted and asked to ensure completeness. Records from centres that had an overall data completion rate of less than 95 per cent were removed from this analysis.

Statistical analysis

Variation across different international health settings was assessed by stratifying participating centres by country into tertiles according to HDI. This is a composite statistic of life expectancy, education and income indices published by the United Nations (http://hdr.undp.org/en/content/human-development-index-hdi). Differences between HDI tertiles were tested with the Pearson χ2 test and Kruskal–Wallis test for categorical and continuous variables respectively. Descriptive percentages are listed as low HDI versus middle HDI versus high HDI throughout for consistency. To account for case mix, mixed-effects, hierarchical multilevel logistic regression models were constructed. Patients nested within countries were considered by a random-effects model. Patient-, disease- and operation-specific variables considered a priori to be candidates in the causal pathway, or confounders to the included outcomes, were included and treated as fixed effects. Model residuals were checked at both levels, checking for first-order interactions; these were included in final models if found to be influential. Final model selection was by minimizing the widely applicable information criterion (variables considered to be marginal candidates in the causal pathway, and that reduced the goodness of the model fit were removed). Any variables with an incident rate below 1 per cent were not taken forwards into the multivariable models. Model discriminative ability was determined using the C-statistic (area under the receiver operator curve, AUC). Coefficients generated were presented as odds ratios (ORs) with 95 per cent confidence intervals. All analyses were performed using the R version 3.1.1 (R Foundation for Statistical Computing, Vienna, Austria) with packages forcats, tidyverse, Hmisc, ggplot2, scales, RColorBrewer, lme4, gmodels, pglm, summariser and pROC.

Results

In total, 1635 patients from 242 hospitals in 57 countries (including 30 LMICs) undergoing left-sided colorectal resection were included in this study (Fig. 1); 113 patients (6·9 per cent) were from low-HDI, 254 (15·5 per cent) from middle-HDI and 1268 (77·6 per cent) from high-HDI countries. Patients from low- and middle-HDI settings were significantly younger, more frequently men, lower risk (ASA grade below III) and less likely to smoke than those in high-HDI settings (Table 1). Patients were more likely to present as an emergency in low-HDI settings (low, 75·2 per cent; middle, 44·9 per cent; high, 45·5 per cent; P < 0·001) (Fig. 2) and more likely to have perforated disease at presentation (57·5, 40·9 and 35·4 per cent respectively; P < 0·001).

Map of included countries
Fig. 1

Map of included countries

Table 1

Baseline demographics of patients undergoing left-sided colorectal resection, grouped by Human Development Index tertile

 High HDI (n = 1268)Middle HDI (n = 254)Low HDI (n = 113)P§
Age (years)*65·9(13·8)53·3(16·6)51·4(16·9)< 0·001
Sex   0·169
  M694 (54·7)137 (53·9)75 (66·4) 
  F533 (42·0)107 (42·1)36 (31·9) 
  Missing41 (3·2)10 (3·9)2 (1·8) 
ASA fitness grade   0·003
  < III706 (55·7)170 (66·9)70 (61·9) 
  ≥ III553 (43·6)80 (31·5)41 (36·3) 
  Missing9 (0·7)4 (1·6)2 (1·8) 
Diabetes   0·133
  No1070 (84·4)219 (86·2)103 (91·2) 
  Yes198 (15·6)35 (13·8)10 (8·8) 
Smoking   0·026
  No884 (69·7)181 (71·3)94 (83·2) 
  Yes271 (21·4)52 (20·5)17 (15·0) 
  Missing113 (8·9)21 (8·3)2 (1·8) 
Malignancy   0·001
  No453 (35·7)106 (41·7)59 (52·2) 
  Yes815 (64·3)148 (58·3)54 (47·8) 
Urgency   < 0·001
  Elective691 (54·5)140 (55·1)28 (24·8) 
  Emergency577 (45·5)114 (44·9)85 (75·2) 
Time to operation (h)   0·001
  < 6233 (18·4)37 (14·6)21 (18·6) 
  6–1189 (7·0)22 (8·7)16 (14·2) 
  12–23273 (21·5)42 (16·5)17 (15·0) 
  24–47272 (21·5)39 (15·4)19 (16·8) 
  ≥ 48368 (29·0)107 (42·1)38 (33·6) 
  Missing33 (2·6)7 (2·8)2 (1·8) 
Laparoscopic   < 0·001
  No892 (70·3)215 (84·6)112 (99·1) 
  Yes376 (29·7)39 (15·4)1 (0·9) 
Perforated disease   < 0·001
  No813 (64·1)147 (57·9)47 (41·6) 
  Yes449 (35·4)104 (40·9)65 (57·5) 
  Missing6 (0·5)3 (1·2)1 (0·9) 
Checklist   < 0·001
  No, not available157 (12·4)40 (15·7)23 (20·4) 
  No, but available37 (2·9)27 (10·6)44 (38·9) 
  Yes1066 (84·1)184 (72·4)46 (40·7) 
  Missing8 (0·6)3 (1·2)0 (0) 
 High HDI (n = 1268)Middle HDI (n = 254)Low HDI (n = 113)P§
Age (years)*65·9(13·8)53·3(16·6)51·4(16·9)< 0·001
Sex   0·169
  M694 (54·7)137 (53·9)75 (66·4) 
  F533 (42·0)107 (42·1)36 (31·9) 
  Missing41 (3·2)10 (3·9)2 (1·8) 
ASA fitness grade   0·003
  < III706 (55·7)170 (66·9)70 (61·9) 
  ≥ III553 (43·6)80 (31·5)41 (36·3) 
  Missing9 (0·7)4 (1·6)2 (1·8) 
Diabetes   0·133
  No1070 (84·4)219 (86·2)103 (91·2) 
  Yes198 (15·6)35 (13·8)10 (8·8) 
Smoking   0·026
  No884 (69·7)181 (71·3)94 (83·2) 
  Yes271 (21·4)52 (20·5)17 (15·0) 
  Missing113 (8·9)21 (8·3)2 (1·8) 
Malignancy   0·001
  No453 (35·7)106 (41·7)59 (52·2) 
  Yes815 (64·3)148 (58·3)54 (47·8) 
Urgency   < 0·001
  Elective691 (54·5)140 (55·1)28 (24·8) 
  Emergency577 (45·5)114 (44·9)85 (75·2) 
Time to operation (h)   0·001
  < 6233 (18·4)37 (14·6)21 (18·6) 
  6–1189 (7·0)22 (8·7)16 (14·2) 
  12–23273 (21·5)42 (16·5)17 (15·0) 
  24–47272 (21·5)39 (15·4)19 (16·8) 
  ≥ 48368 (29·0)107 (42·1)38 (33·6) 
  Missing33 (2·6)7 (2·8)2 (1·8) 
Laparoscopic   < 0·001
  No892 (70·3)215 (84·6)112 (99·1) 
  Yes376 (29·7)39 (15·4)1 (0·9) 
Perforated disease   < 0·001
  No813 (64·1)147 (57·9)47 (41·6) 
  Yes449 (35·4)104 (40·9)65 (57·5) 
  Missing6 (0·5)3 (1·2)1 (0·9) 
Checklist   < 0·001
  No, not available157 (12·4)40 (15·7)23 (20·4) 
  No, but available37 (2·9)27 (10·6)44 (38·9) 
  Yes1066 (84·1)184 (72·4)46 (40·7) 
  Missing8 (0·6)3 (1·2)0 (0) 

Values in parentheses are percentages by column, unless indicated otherwise;

*

values are mean(s.d.).

Time from presentation to index procedure.

WHO Surgical Safety Checklist. HDI, Human Development Index.

§

Pearson χ2 test, except

Kruskal–Wallis test.

Table 1

Baseline demographics of patients undergoing left-sided colorectal resection, grouped by Human Development Index tertile

 High HDI (n = 1268)Middle HDI (n = 254)Low HDI (n = 113)P§
Age (years)*65·9(13·8)53·3(16·6)51·4(16·9)< 0·001
Sex   0·169
  M694 (54·7)137 (53·9)75 (66·4) 
  F533 (42·0)107 (42·1)36 (31·9) 
  Missing41 (3·2)10 (3·9)2 (1·8) 
ASA fitness grade   0·003
  < III706 (55·7)170 (66·9)70 (61·9) 
  ≥ III553 (43·6)80 (31·5)41 (36·3) 
  Missing9 (0·7)4 (1·6)2 (1·8) 
Diabetes   0·133
  No1070 (84·4)219 (86·2)103 (91·2) 
  Yes198 (15·6)35 (13·8)10 (8·8) 
Smoking   0·026
  No884 (69·7)181 (71·3)94 (83·2) 
  Yes271 (21·4)52 (20·5)17 (15·0) 
  Missing113 (8·9)21 (8·3)2 (1·8) 
Malignancy   0·001
  No453 (35·7)106 (41·7)59 (52·2) 
  Yes815 (64·3)148 (58·3)54 (47·8) 
Urgency   < 0·001
  Elective691 (54·5)140 (55·1)28 (24·8) 
  Emergency577 (45·5)114 (44·9)85 (75·2) 
Time to operation (h)   0·001
  < 6233 (18·4)37 (14·6)21 (18·6) 
  6–1189 (7·0)22 (8·7)16 (14·2) 
  12–23273 (21·5)42 (16·5)17 (15·0) 
  24–47272 (21·5)39 (15·4)19 (16·8) 
  ≥ 48368 (29·0)107 (42·1)38 (33·6) 
  Missing33 (2·6)7 (2·8)2 (1·8) 
Laparoscopic   < 0·001
  No892 (70·3)215 (84·6)112 (99·1) 
  Yes376 (29·7)39 (15·4)1 (0·9) 
Perforated disease   < 0·001
  No813 (64·1)147 (57·9)47 (41·6) 
  Yes449 (35·4)104 (40·9)65 (57·5) 
  Missing6 (0·5)3 (1·2)1 (0·9) 
Checklist   < 0·001
  No, not available157 (12·4)40 (15·7)23 (20·4) 
  No, but available37 (2·9)27 (10·6)44 (38·9) 
  Yes1066 (84·1)184 (72·4)46 (40·7) 
  Missing8 (0·6)3 (1·2)0 (0) 
 High HDI (n = 1268)Middle HDI (n = 254)Low HDI (n = 113)P§
Age (years)*65·9(13·8)53·3(16·6)51·4(16·9)< 0·001
Sex   0·169
  M694 (54·7)137 (53·9)75 (66·4) 
  F533 (42·0)107 (42·1)36 (31·9) 
  Missing41 (3·2)10 (3·9)2 (1·8) 
ASA fitness grade   0·003
  < III706 (55·7)170 (66·9)70 (61·9) 
  ≥ III553 (43·6)80 (31·5)41 (36·3) 
  Missing9 (0·7)4 (1·6)2 (1·8) 
Diabetes   0·133
  No1070 (84·4)219 (86·2)103 (91·2) 
  Yes198 (15·6)35 (13·8)10 (8·8) 
Smoking   0·026
  No884 (69·7)181 (71·3)94 (83·2) 
  Yes271 (21·4)52 (20·5)17 (15·0) 
  Missing113 (8·9)21 (8·3)2 (1·8) 
Malignancy   0·001
  No453 (35·7)106 (41·7)59 (52·2) 
  Yes815 (64·3)148 (58·3)54 (47·8) 
Urgency   < 0·001
  Elective691 (54·5)140 (55·1)28 (24·8) 
  Emergency577 (45·5)114 (44·9)85 (75·2) 
Time to operation (h)   0·001
  < 6233 (18·4)37 (14·6)21 (18·6) 
  6–1189 (7·0)22 (8·7)16 (14·2) 
  12–23273 (21·5)42 (16·5)17 (15·0) 
  24–47272 (21·5)39 (15·4)19 (16·8) 
  ≥ 48368 (29·0)107 (42·1)38 (33·6) 
  Missing33 (2·6)7 (2·8)2 (1·8) 
Laparoscopic   < 0·001
  No892 (70·3)215 (84·6)112 (99·1) 
  Yes376 (29·7)39 (15·4)1 (0·9) 
Perforated disease   < 0·001
  No813 (64·1)147 (57·9)47 (41·6) 
  Yes449 (35·4)104 (40·9)65 (57·5) 
  Missing6 (0·5)3 (1·2)1 (0·9) 
Checklist   < 0·001
  No, not available157 (12·4)40 (15·7)23 (20·4) 
  No, but available37 (2·9)27 (10·6)44 (38·9) 
  Yes1066 (84·1)184 (72·4)46 (40·7) 
  Missing8 (0·6)3 (1·2)0 (0) 

Values in parentheses are percentages by column, unless indicated otherwise;

*

values are mean(s.d.).

Time from presentation to index procedure.

WHO Surgical Safety Checklist. HDI, Human Development Index.

§

Pearson χ2 test, except

Kruskal–Wallis test.

Presentation of patients undergoing left-sided colorectal resection by Human Development Index tertile. HDI, Human Development Index
Fig. 2

Presentation of patients undergoing left-sided colorectal resection by Human Development Index tertile. HDI, Human Development Index

Disease profiles in patients from low-HDI settings were different from those in middle- and high-HDI settings (Fig. 3). Fewer procedures were performed for malignancy (47·8, 58·3 and 64·3 per cent respectively; P = 0·001), diverticulitis (1·7, 4·3 and 14·2 per cent; P < 0·001) and inflammatory bowel disease (0, 1·6 and 1·4 per cent; P = 0·007), but a greater proportion of procedures were for volvulus (21·2, 7·5 and 2·4 per cent; P < 0·001) and trauma (9·7, 8·3 and 0·8 per cent respectively; P < 0·001). An overall delay from presentation to surgery of at least 48 h was more common in both low- and middle-HDI than high-HDI countries (33·6, 42·1 and 29·0 per cent; P < 0·001). A WHO checklist was used in only 40·7 per cent of operations in low-HDI countries compared with 72·4 and 84·1 per cent in middle- and high-HDI countries respectively. Half as many patients in middle-HDI countries had a planned laparoscopic operation than in high-HDI countries (15·4 versus 29·7 per cent; P < 0·001). Only one patient from a low-HDI country had laparoscopic surgery (this was subsequently excluded from the mixed-effects models).

Indications for left-sided colorectal resection by Human Development Index tertile and urgency of surgery. a Elective and b emergency. HDI, Human Development Index
Fig. 3

Indications for left-sided colorectal resection by Human Development Index tertile and urgency of surgery. a Elective and b emergency. HDI, Human Development Index

Variation in rates of end colostomy formation

Some 362 patients received an end colostomy (22·1 per cent) and 1273 a primary anastomosis (77·9 per cent) (Table 2). Of patients with an anastomosis, 211 (16·6 per cent) underwent left hemicolectomy, 40 (3·1 per cent) transverse or extended left hemicolectomy, 611 (48·0 per cent) sigmoid colectomy and 411 (32·3 per cent) rectal resection. Patients who received an end colostomy were more commonly high risk (ASA at least grade III: 48·9 versus 39·0 per cent; P = 0·004), had a benign indication (including trauma: 43·9 versus 36·1 per cent; P = 0·006) and perforated disease (66·6 versus 29·6 per cent; P < 0·001). Emergency surgery (77·1 versus 39·0 per cent; P < 0·001), open surgery (85·9 versus 71·3 per cent; P < 0·001) and a delay to surgery of 48 h or more (43·4 versus 28·0 per cent; P < 0·001) were also more common in the end colostomy group. Patients underwent formation of an end colostomy twice as frequently in low- compared with middle- or high-HDI countries (52·2, 24·8 and 18·9 per cent; P < 0·001). Fig. 4 shows end colostomy formation rates across HDI strata, indications for surgery and the presence or absence of perforated disease.

Table 2

Baseline demographics of patients undergoing left-sided colorectal resection, grouped by whether they underwent end colostomy formation or primary restorative anastomosis

 Anastomosis (n = 1273)End colostomy (n = 362)P§
HDI tertile  < 0·001
  High1028 (81·1)240 (18·9) 
  Middle191 (75·2)63 (24·8) 
  Low54 (47·8)59 (52·2) 
Age (years)*63·6(14·5)60·5(18·4)0·025
Sex  0·108
  M714 (78·8)192 (21·2) 
  F513 (75·9)163 (24·1) 
  Missing46 (87)7 (13) 
ASA grade  0·004
  < III764 (80·8)182 (19·2) 
  ≥ III497 (73·7)177 (26·3) 
  Missing12 (80)3 (20) 
Diabetes  0·524
  No1080 (77·6)312 (22·4) 
  Yes193 (79·4)50 (20·6) 
Smoking  0·122
  No918 (79·2)241 (20·8) 
  Yes253 (74·4)87 (25·6) 
  Missing102 (75·0)34 (25·0) 
Malignancy  0·006
  No459 (74·3)159 (25·7) 
  Yes814 (80·0)203 (20·0) 
Urgency  < 0·001
  Elective776 (90·3)83 (9·7) 
  Emergency497 (64·0)279 (36·0) 
Time to operation (h)  < 0·001
  < 6230 (79·0)61 (21·0) 
  6–11101 (79·5)26 (20·5) 
  12–23283 (85·2)49 (14·8) 
  24–47268 (81·2)62 (18·8) 
  ≥ 48356 (69·4)157 (30·6) 
  Missing35 (83)7 (17) 
Laparoscopic  < 0·001
  No908 (74·5)311 (25·5) 
  Yes365 (87·7)51 (12·3) 
Perforated disease  < 0·001
  No887 (88·1)120 (11·9) 
  Yes377 (61·0)241 (39·0) 
  Missing9 (90)1 (10) 
Checklist  0·047
  No, not available178 (80·9)42 (19·1) 
  No, but available73 (67·6)35 (32·4) 
  Yes1013 (78·2)283 (21·8) 
  Missing9 (82)2 (18) 
 Anastomosis (n = 1273)End colostomy (n = 362)P§
HDI tertile  < 0·001
  High1028 (81·1)240 (18·9) 
  Middle191 (75·2)63 (24·8) 
  Low54 (47·8)59 (52·2) 
Age (years)*63·6(14·5)60·5(18·4)0·025
Sex  0·108
  M714 (78·8)192 (21·2) 
  F513 (75·9)163 (24·1) 
  Missing46 (87)7 (13) 
ASA grade  0·004
  < III764 (80·8)182 (19·2) 
  ≥ III497 (73·7)177 (26·3) 
  Missing12 (80)3 (20) 
Diabetes  0·524
  No1080 (77·6)312 (22·4) 
  Yes193 (79·4)50 (20·6) 
Smoking  0·122
  No918 (79·2)241 (20·8) 
  Yes253 (74·4)87 (25·6) 
  Missing102 (75·0)34 (25·0) 
Malignancy  0·006
  No459 (74·3)159 (25·7) 
  Yes814 (80·0)203 (20·0) 
Urgency  < 0·001
  Elective776 (90·3)83 (9·7) 
  Emergency497 (64·0)279 (36·0) 
Time to operation (h)  < 0·001
  < 6230 (79·0)61 (21·0) 
  6–11101 (79·5)26 (20·5) 
  12–23283 (85·2)49 (14·8) 
  24–47268 (81·2)62 (18·8) 
  ≥ 48356 (69·4)157 (30·6) 
  Missing35 (83)7 (17) 
Laparoscopic  < 0·001
  No908 (74·5)311 (25·5) 
  Yes365 (87·7)51 (12·3) 
Perforated disease  < 0·001
  No887 (88·1)120 (11·9) 
  Yes377 (61·0)241 (39·0) 
  Missing9 (90)1 (10) 
Checklist  0·047
  No, not available178 (80·9)42 (19·1) 
  No, but available73 (67·6)35 (32·4) 
  Yes1013 (78·2)283 (21·8) 
  Missing9 (82)2 (18) 

Values in parentheses are percentages by row, unless indicated otherwise;

*

values are mean(s.d.).

Time from presentation to index procedure.

WHO Surgical Safety Checklist. HDI, Human Development Index.

§

Pearson χ2 test, except

Kruskal–Wallis test.

Table 2

Baseline demographics of patients undergoing left-sided colorectal resection, grouped by whether they underwent end colostomy formation or primary restorative anastomosis

 Anastomosis (n = 1273)End colostomy (n = 362)P§
HDI tertile  < 0·001
  High1028 (81·1)240 (18·9) 
  Middle191 (75·2)63 (24·8) 
  Low54 (47·8)59 (52·2) 
Age (years)*63·6(14·5)60·5(18·4)0·025
Sex  0·108
  M714 (78·8)192 (21·2) 
  F513 (75·9)163 (24·1) 
  Missing46 (87)7 (13) 
ASA grade  0·004
  < III764 (80·8)182 (19·2) 
  ≥ III497 (73·7)177 (26·3) 
  Missing12 (80)3 (20) 
Diabetes  0·524
  No1080 (77·6)312 (22·4) 
  Yes193 (79·4)50 (20·6) 
Smoking  0·122
  No918 (79·2)241 (20·8) 
  Yes253 (74·4)87 (25·6) 
  Missing102 (75·0)34 (25·0) 
Malignancy  0·006
  No459 (74·3)159 (25·7) 
  Yes814 (80·0)203 (20·0) 
Urgency  < 0·001
  Elective776 (90·3)83 (9·7) 
  Emergency497 (64·0)279 (36·0) 
Time to operation (h)  < 0·001
  < 6230 (79·0)61 (21·0) 
  6–11101 (79·5)26 (20·5) 
  12–23283 (85·2)49 (14·8) 
  24–47268 (81·2)62 (18·8) 
  ≥ 48356 (69·4)157 (30·6) 
  Missing35 (83)7 (17) 
Laparoscopic  < 0·001
  No908 (74·5)311 (25·5) 
  Yes365 (87·7)51 (12·3) 
Perforated disease  < 0·001
  No887 (88·1)120 (11·9) 
  Yes377 (61·0)241 (39·0) 
  Missing9 (90)1 (10) 
Checklist  0·047
  No, not available178 (80·9)42 (19·1) 
  No, but available73 (67·6)35 (32·4) 
  Yes1013 (78·2)283 (21·8) 
  Missing9 (82)2 (18) 
 Anastomosis (n = 1273)End colostomy (n = 362)P§
HDI tertile  < 0·001
  High1028 (81·1)240 (18·9) 
  Middle191 (75·2)63 (24·8) 
  Low54 (47·8)59 (52·2) 
Age (years)*63·6(14·5)60·5(18·4)0·025
Sex  0·108
  M714 (78·8)192 (21·2) 
  F513 (75·9)163 (24·1) 
  Missing46 (87)7 (13) 
ASA grade  0·004
  < III764 (80·8)182 (19·2) 
  ≥ III497 (73·7)177 (26·3) 
  Missing12 (80)3 (20) 
Diabetes  0·524
  No1080 (77·6)312 (22·4) 
  Yes193 (79·4)50 (20·6) 
Smoking  0·122
  No918 (79·2)241 (20·8) 
  Yes253 (74·4)87 (25·6) 
  Missing102 (75·0)34 (25·0) 
Malignancy  0·006
  No459 (74·3)159 (25·7) 
  Yes814 (80·0)203 (20·0) 
Urgency  < 0·001
  Elective776 (90·3)83 (9·7) 
  Emergency497 (64·0)279 (36·0) 
Time to operation (h)  < 0·001
  < 6230 (79·0)61 (21·0) 
  6–11101 (79·5)26 (20·5) 
  12–23283 (85·2)49 (14·8) 
  24–47268 (81·2)62 (18·8) 
  ≥ 48356 (69·4)157 (30·6) 
  Missing35 (83)7 (17) 
Laparoscopic  < 0·001
  No908 (74·5)311 (25·5) 
  Yes365 (87·7)51 (12·3) 
Perforated disease  < 0·001
  No887 (88·1)120 (11·9) 
  Yes377 (61·0)241 (39·0) 
  Missing9 (90)1 (10) 
Checklist  0·047
  No, not available178 (80·9)42 (19·1) 
  No, but available73 (67·6)35 (32·4) 
  Yes1013 (78·2)283 (21·8) 
  Missing9 (82)2 (18) 

Values in parentheses are percentages by row, unless indicated otherwise;

*

values are mean(s.d.).

Time from presentation to index procedure.

WHO Surgical Safety Checklist. HDI, Human Development Index.

§

Pearson χ2 test, except

Kruskal–Wallis test.

End colostomy formation rates by Human Development Index tertile, indication for surgery and presence of perforated disease. HDI, Human Development Index
Fig. 4

End colostomy formation rates by Human Development Index tertile, indication for surgery and presence of perforated disease. HDI, Human Development Index

In univariable analysis, middle-HDI (OR 1·41, 95 per cent c.i. 1·02 to 1·93; P = 0·033) and low-HDI (OR 4·68, 3·15 to 6·96; P < 0·001) tertile were both strongly associated with end colostomy formation, as were ASA grade III or higher, malignancy, emergency surgery, a time to operation of 12–23 h or 48 h and over, perforated disease and absence of checklist use where it was available (Table 3). In the multilevel model, low-HDI tertile retained an association with colostomy formation (OR 3·20, 1·35 to 7·57; P = 0·008), despite adjustment for malignant disease (OR 2·34, 1·65 to 3·32; P < 0·001), emergency surgery (OR 4·08, 2·73 to 6·10; P < 0·001), a time to operation of 48 h or longer (OR 1·99, 1·28 to 3·09; P = 0·002) and perforation (OR 4·00, 2·81 to 5·69; P < 0·001). The model demonstrated excellent discrimination (AUC 0·85) (Table 3).

Table 3

Factors associated with end colostomy formation in univariable and multilevel mixed-effects logistic regression models

   Univariable analysisMultilevel analysis
 AnastomosisEnd colostomyOdds ratio*POdds ratio*P
HDI tertile      
  High1028 (80·8)240 (66·3)1·00 (reference) 1·00 (reference) 
  Middle191 (15·0)63 (17·4)1·41 (1·02, 1·93)0·0331·11 (0·53, 2·32)0·777
  Low54 (4·2)59 (16·3)4·68 (3·15, 6·96)< 0·0013·20 (1·35, 7·57)0·008
Age (years)63·6(14·5)60·5(18·4)0·99 (0·98, 0·99)0·0010·99 (0·98, 1·00)0·061
Sex      
  M714 (58·2)192 (54·1)1·00 (reference) 1·00 (reference) 
  F513 (41·8)163 (45·9)1·18 (0·93, 1·50)0·1691·17 (0·85, 1·59)0·338
ASA fitness grade      
  < III764 (60·6)182 (50·7)1·00 (reference) 1·00 (reference) 
  ≥ III497 (39·4)177 (49·3)1·49 (1·18, 1·89)0·0011·22 (0·87, 1·71)0·256
Diabetes      
  No1080 (84·8)312 (86·2)1·00 (reference) 1·00 (reference) 
  Yes193 (15·2)50 (13·8)0·90 (0·64, 1·25)0·5251·08 (0·69, 1·68)0·744
Smoking      
  No918 (78·4)241 (73·5)1·00 (reference) 1·00 (reference) 
  Yes253 (21·6)87 (26·5)1·31 (0·98, 1·73)0·0610·97 (0·68, 1·39)0·889
Malignancy      
  No459 (36·1)159 (43·9)1·00 (reference) 1·00 (reference) 
  Yes814 (63·9)203 (56·1)0·72 (0·57, 0·91)0·0072·34 (1·65, 3·32)< 0·001
Urgency      
  Elective776 (61·0)83 (22·9)1·00 (reference) 1·00 (reference) 
  Emergency497 (39·0)279 (77·1)5·25 (4·03, 6·91)< 0·0014·08 (2·73, 6·10)< 0·001
Time to operation (h)      
  < 6230 (18·6)61 (17·2)1·00 (reference) 1·00 (reference) 
  6–11101 (8·2)26 (7·3)0·97 (0·57, 1·61)0·9100·65 (0·34, 1·23)0·184
  12–23283 (22·9)49 (13·8)0·65 (0·43, 0·99)0·0440·76 (0·44, 1·29)0·308
  24–47268 (21·6)62 (17·5)0·87 (0·59, 1·30)0·4981·24 (0·73, 2·11)0·424
  ≥ 48356 (28·8)157 (44·2)1·66 (1·19, 2·35)0·0031·99 (1·28, 3·09)0·002
Laparoscopic§      
  No908 (71·3)311 (85·9)1·00 (reference)  
  Yes365 (28·7)51 (14·1)0·41 (0·29, 0·56)< 0·001 
Perforated disease      
  No887 (70·2)120 (33·2)1·00 (reference) 1·00 (reference) 
  Yes377 (29·8)241 (66·8)4·73 (3·69, 6·08)< 0·0014·00 (2·81, 5·69)< 0·001
Checklist      
  No, not available178 (14·1)42 (11·7)1·00 (reference) 1·00 (reference) 
  No, but available73 (5·8)35 (9·7)2·03 (1·20, 3·44)0·0081·10 (0·50, 2·41)0·813
  Yes1013 (80·1)283 (78·6)1·18 (0·83, 1·72)0·3590·83 (0·44, 1·58)0·576
   Univariable analysisMultilevel analysis
 AnastomosisEnd colostomyOdds ratio*POdds ratio*P
HDI tertile      
  High1028 (80·8)240 (66·3)1·00 (reference) 1·00 (reference) 
  Middle191 (15·0)63 (17·4)1·41 (1·02, 1·93)0·0331·11 (0·53, 2·32)0·777
  Low54 (4·2)59 (16·3)4·68 (3·15, 6·96)< 0·0013·20 (1·35, 7·57)0·008
Age (years)63·6(14·5)60·5(18·4)0·99 (0·98, 0·99)0·0010·99 (0·98, 1·00)0·061
Sex      
  M714 (58·2)192 (54·1)1·00 (reference) 1·00 (reference) 
  F513 (41·8)163 (45·9)1·18 (0·93, 1·50)0·1691·17 (0·85, 1·59)0·338
ASA fitness grade      
  < III764 (60·6)182 (50·7)1·00 (reference) 1·00 (reference) 
  ≥ III497 (39·4)177 (49·3)1·49 (1·18, 1·89)0·0011·22 (0·87, 1·71)0·256
Diabetes      
  No1080 (84·8)312 (86·2)1·00 (reference) 1·00 (reference) 
  Yes193 (15·2)50 (13·8)0·90 (0·64, 1·25)0·5251·08 (0·69, 1·68)0·744
Smoking      
  No918 (78·4)241 (73·5)1·00 (reference) 1·00 (reference) 
  Yes253 (21·6)87 (26·5)1·31 (0·98, 1·73)0·0610·97 (0·68, 1·39)0·889
Malignancy      
  No459 (36·1)159 (43·9)1·00 (reference) 1·00 (reference) 
  Yes814 (63·9)203 (56·1)0·72 (0·57, 0·91)0·0072·34 (1·65, 3·32)< 0·001
Urgency      
  Elective776 (61·0)83 (22·9)1·00 (reference) 1·00 (reference) 
  Emergency497 (39·0)279 (77·1)5·25 (4·03, 6·91)< 0·0014·08 (2·73, 6·10)< 0·001
Time to operation (h)      
  < 6230 (18·6)61 (17·2)1·00 (reference) 1·00 (reference) 
  6–11101 (8·2)26 (7·3)0·97 (0·57, 1·61)0·9100·65 (0·34, 1·23)0·184
  12–23283 (22·9)49 (13·8)0·65 (0·43, 0·99)0·0440·76 (0·44, 1·29)0·308
  24–47268 (21·6)62 (17·5)0·87 (0·59, 1·30)0·4981·24 (0·73, 2·11)0·424
  ≥ 48356 (28·8)157 (44·2)1·66 (1·19, 2·35)0·0031·99 (1·28, 3·09)0·002
Laparoscopic§      
  No908 (71·3)311 (85·9)1·00 (reference)  
  Yes365 (28·7)51 (14·1)0·41 (0·29, 0·56)< 0·001 
Perforated disease      
  No887 (70·2)120 (33·2)1·00 (reference) 1·00 (reference) 
  Yes377 (29·8)241 (66·8)4·73 (3·69, 6·08)< 0·0014·00 (2·81, 5·69)< 0·001
Checklist      
  No, not available178 (14·1)42 (11·7)1·00 (reference) 1·00 (reference) 
  No, but available73 (5·8)35 (9·7)2·03 (1·20, 3·44)0·0081·10 (0·50, 2·41)0·813
  Yes1013 (80·1)283 (78·6)1·18 (0·83, 1·72)0·3590·83 (0·44, 1·58)0·576

Values in parentheses are percentages by column unless indicated otherwise;

*

values in parentheses are 95 per cent confidence intervals and

values are mean(s.d.).

Time from presentation to index procedure.

§

Not included in multilevel model owing to low event rate in low-Human Development Index (HDI) tertile (less than 1 per cent).

WHO Surgical Safety Checklist.

Table 3

Factors associated with end colostomy formation in univariable and multilevel mixed-effects logistic regression models

   Univariable analysisMultilevel analysis
 AnastomosisEnd colostomyOdds ratio*POdds ratio*P
HDI tertile      
  High1028 (80·8)240 (66·3)1·00 (reference) 1·00 (reference) 
  Middle191 (15·0)63 (17·4)1·41 (1·02, 1·93)0·0331·11 (0·53, 2·32)0·777
  Low54 (4·2)59 (16·3)4·68 (3·15, 6·96)< 0·0013·20 (1·35, 7·57)0·008
Age (years)63·6(14·5)60·5(18·4)0·99 (0·98, 0·99)0·0010·99 (0·98, 1·00)0·061
Sex      
  M714 (58·2)192 (54·1)1·00 (reference) 1·00 (reference) 
  F513 (41·8)163 (45·9)1·18 (0·93, 1·50)0·1691·17 (0·85, 1·59)0·338
ASA fitness grade      
  < III764 (60·6)182 (50·7)1·00 (reference) 1·00 (reference) 
  ≥ III497 (39·4)177 (49·3)1·49 (1·18, 1·89)0·0011·22 (0·87, 1·71)0·256
Diabetes      
  No1080 (84·8)312 (86·2)1·00 (reference) 1·00 (reference) 
  Yes193 (15·2)50 (13·8)0·90 (0·64, 1·25)0·5251·08 (0·69, 1·68)0·744
Smoking      
  No918 (78·4)241 (73·5)1·00 (reference) 1·00 (reference) 
  Yes253 (21·6)87 (26·5)1·31 (0·98, 1·73)0·0610·97 (0·68, 1·39)0·889
Malignancy      
  No459 (36·1)159 (43·9)1·00 (reference) 1·00 (reference) 
  Yes814 (63·9)203 (56·1)0·72 (0·57, 0·91)0·0072·34 (1·65, 3·32)< 0·001
Urgency      
  Elective776 (61·0)83 (22·9)1·00 (reference) 1·00 (reference) 
  Emergency497 (39·0)279 (77·1)5·25 (4·03, 6·91)< 0·0014·08 (2·73, 6·10)< 0·001
Time to operation (h)      
  < 6230 (18·6)61 (17·2)1·00 (reference) 1·00 (reference) 
  6–11101 (8·2)26 (7·3)0·97 (0·57, 1·61)0·9100·65 (0·34, 1·23)0·184
  12–23283 (22·9)49 (13·8)0·65 (0·43, 0·99)0·0440·76 (0·44, 1·29)0·308
  24–47268 (21·6)62 (17·5)0·87 (0·59, 1·30)0·4981·24 (0·73, 2·11)0·424
  ≥ 48356 (28·8)157 (44·2)1·66 (1·19, 2·35)0·0031·99 (1·28, 3·09)0·002
Laparoscopic§      
  No908 (71·3)311 (85·9)1·00 (reference)  
  Yes365 (28·7)51 (14·1)0·41 (0·29, 0·56)< 0·001 
Perforated disease      
  No887 (70·2)120 (33·2)1·00 (reference) 1·00 (reference) 
  Yes377 (29·8)241 (66·8)4·73 (3·69, 6·08)< 0·0014·00 (2·81, 5·69)< 0·001
Checklist      
  No, not available178 (14·1)42 (11·7)1·00 (reference) 1·00 (reference) 
  No, but available73 (5·8)35 (9·7)2·03 (1·20, 3·44)0·0081·10 (0·50, 2·41)0·813
  Yes1013 (80·1)283 (78·6)1·18 (0·83, 1·72)0·3590·83 (0·44, 1·58)0·576
   Univariable analysisMultilevel analysis
 AnastomosisEnd colostomyOdds ratio*POdds ratio*P
HDI tertile      
  High1028 (80·8)240 (66·3)1·00 (reference) 1·00 (reference) 
  Middle191 (15·0)63 (17·4)1·41 (1·02, 1·93)0·0331·11 (0·53, 2·32)0·777
  Low54 (4·2)59 (16·3)4·68 (3·15, 6·96)< 0·0013·20 (1·35, 7·57)0·008
Age (years)63·6(14·5)60·5(18·4)0·99 (0·98, 0·99)0·0010·99 (0·98, 1·00)0·061
Sex      
  M714 (58·2)192 (54·1)1·00 (reference) 1·00 (reference) 
  F513 (41·8)163 (45·9)1·18 (0·93, 1·50)0·1691·17 (0·85, 1·59)0·338
ASA fitness grade      
  < III764 (60·6)182 (50·7)1·00 (reference) 1·00 (reference) 
  ≥ III497 (39·4)177 (49·3)1·49 (1·18, 1·89)0·0011·22 (0·87, 1·71)0·256
Diabetes      
  No1080 (84·8)312 (86·2)1·00 (reference) 1·00 (reference) 
  Yes193 (15·2)50 (13·8)0·90 (0·64, 1·25)0·5251·08 (0·69, 1·68)0·744
Smoking      
  No918 (78·4)241 (73·5)1·00 (reference) 1·00 (reference) 
  Yes253 (21·6)87 (26·5)1·31 (0·98, 1·73)0·0610·97 (0·68, 1·39)0·889
Malignancy      
  No459 (36·1)159 (43·9)1·00 (reference) 1·00 (reference) 
  Yes814 (63·9)203 (56·1)0·72 (0·57, 0·91)0·0072·34 (1·65, 3·32)< 0·001
Urgency      
  Elective776 (61·0)83 (22·9)1·00 (reference) 1·00 (reference) 
  Emergency497 (39·0)279 (77·1)5·25 (4·03, 6·91)< 0·0014·08 (2·73, 6·10)< 0·001
Time to operation (h)      
  < 6230 (18·6)61 (17·2)1·00 (reference) 1·00 (reference) 
  6–11101 (8·2)26 (7·3)0·97 (0·57, 1·61)0·9100·65 (0·34, 1·23)0·184
  12–23283 (22·9)49 (13·8)0·65 (0·43, 0·99)0·0440·76 (0·44, 1·29)0·308
  24–47268 (21·6)62 (17·5)0·87 (0·59, 1·30)0·4981·24 (0·73, 2·11)0·424
  ≥ 48356 (28·8)157 (44·2)1·66 (1·19, 2·35)0·0031·99 (1·28, 3·09)0·002
Laparoscopic§      
  No908 (71·3)311 (85·9)1·00 (reference)  
  Yes365 (28·7)51 (14·1)0·41 (0·29, 0·56)< 0·001 
Perforated disease      
  No887 (70·2)120 (33·2)1·00 (reference) 1·00 (reference) 
  Yes377 (29·8)241 (66·8)4·73 (3·69, 6·08)< 0·0014·00 (2·81, 5·69)< 0·001
Checklist      
  No, not available178 (14·1)42 (11·7)1·00 (reference) 1·00 (reference) 
  No, but available73 (5·8)35 (9·7)2·03 (1·20, 3·44)0·0081·10 (0·50, 2·41)0·813
  Yes1013 (80·1)283 (78·6)1·18 (0·83, 1·72)0·3590·83 (0·44, 1·58)0·576

Values in parentheses are percentages by column unless indicated otherwise;

*

values in parentheses are 95 per cent confidence intervals and

values are mean(s.d.).

Time from presentation to index procedure.

§

Not included in multilevel model owing to low event rate in low-Human Development Index (HDI) tertile (less than 1 per cent).

WHO Surgical Safety Checklist.

Variation in mortality

The unadjusted 30-day postoperative mortality rates were three times higher in low-HDI countries than in middle- and high-HDI settings (15·9, 5·5 and 4·6 per cent respectively) (Fig. 5). Patients with an end colostomy had a significantly higher risk of death (adjusted OR 2·18, 95 per cent 1·23 to 3·85; P = 0·007), as did those from a low-HDI tertile (OR 2·80, 1·00 to 7·82; P = 0·050), older patients, those with an ASA grade of at least III, patients having emergency surgery, and those with a delay to surgery of 24–47 h (Table 4). The benefit of use of the WHO Checklist in theatre reached borderline significance (OR 0·50, 0·22 to 1·13; P = 0·094). The model demonstrated excellent discrimination (AUC 0·89).

Percentage of patients who died within 30 days after left-sided colorectal resection by Human Development Index tertile and urgency of surgery. a Elective and b emergency. HDI, Human Development Index
Fig. 5

Percentage of patients who died within 30 days after left-sided colorectal resection by Human Development Index tertile and urgency of surgery. a Elective and b emergency. HDI, Human Development Index

Table 4

Factors associated with mortality in patients undergoing left-sided colorectal resection in univariable and multilevel, multivariable logistic regression models

   Univariable analysisMultilevel analysis
 AliveDiedOdds ratio*POdds ratio*P
HDI tertile      
  High1200 (78·8)58 (64)1·00 (reference) 1·00 (reference) 
  Middle229 (15·0)14 (16)1·26 (0·67, 2·24)0·4431·60 (0·64, 3·97)0·313
  Low93 (6·1)18 (20)4·00 (2·21, 6·95)< 0·0012·80 (1·00, 7·82)0·050
Age (years)62·7(15·3)69·1(15·9)1·03 (1·02, 1·05) 1·03 (1·01, 1·05)0·001
Sex      
  M847 (57·5)44 (51)1·00 (reference) 1·00 (reference) 
  F625 (42·5)43 (49)1·32 (0·86, 2·04)0·2031·40 (0·82, 2·39)0·214
ASA fitness grade      
  < III921 (61·0)16 (18)1·00 (reference) 1·00 (reference) 
  ≥ III589 (39·0)74 (82)7·23 (4·29, 12·97)< 0·0016·16 (3·12, 12·19)< 0·001
Diabetes      
  No1296 (85·2)75 (83)1·00 (reference) 1·00 (reference) 
  Yes226 (14·8)15 (17)1·15 (0·62, 1·98)0·6390·86 (0·43, 1·73)0·681
Smoking      
  No1077 (77·3)68 (78)1·00 (reference) 1·00 (reference) 
  Yes316 (22·7)19 (22)0·95 (0·55, 1·58)0·8550·73 (0·39, 1·39)0·345
Malignancy      
  No558 (36·7)50 (56)1·00 (reference) 1·00 (reference) 
  Yes964 (63·3)40 (44)0·46 (0·30, 0·71)< 0·0010·83 (0·48, 1·44)0·503
Urgency      
  Elective837 (55·0)9 (10)1·00 (reference) 1·00 (reference) 
  Emergency685 (45·0)81 (90)11·00 (5·79, 23·68)< 0·0014·92 (2·18, 11·13)< 0·001
Time to operation (h)      
  < 6267 (18·0)18 (21)1·00 (reference) 1·00 (reference) 
  6–11111 (7·5)15 (17)2·00 (0·96, 4·12)0·0581·12 (0·46, 2·72)0·800
  12–23314 (21·2)17 (19)0·80 (0·40, 1·60)0·5290·98 (0·43, 2·19)0·952
  24–47320 (21·6)5 (6)0·23 (0·08, 0·59)0·0040·21 (0·06, 0·70)0·011
  ≥ 48470 (31·7)33 (38)1·04 (0·58, 1·92)0·8930·78 (0·39, 1·59)0·497
Laparoscopic§      
  No1115 (73·3)85 (94)1·00 (reference)  
  Yes407 (26·7)5 (6)0·16 (0·06, 0·36)< 0·001 
Perforated disease      
  No961 (63·5)32 (36)1·00 (reference) 1·00 (reference) 
  Yes552 (36·5)57 (64)3·10 (2·00, 4·89)< 0·0011·07 (0·59, 1·92)0·833
Checklist      
  No, not available197 (13·0)17 (19)1·00 (reference) 1·00 (reference) 
  No, but available92 (6·1)12 (13)1·51 (0·68, 3·27)0·2991·38 (0·46, 4·11)0·564
  Yes1223 (80·9)61 (68)0·58 (0·34, 1·04)0·0540·50 (0·22, 1·13)0·094
  Anastomosis/colostomy      
  Anastomosis1208 (79·4)48 (53)1·00 (reference) 1·00 (reference) 
  End colostomy314 (20·6)42 (47)3·37 (2·18, 5·19)< 0·0012·18 (1·23, 3·85)0·007
   Univariable analysisMultilevel analysis
 AliveDiedOdds ratio*POdds ratio*P
HDI tertile      
  High1200 (78·8)58 (64)1·00 (reference) 1·00 (reference) 
  Middle229 (15·0)14 (16)1·26 (0·67, 2·24)0·4431·60 (0·64, 3·97)0·313
  Low93 (6·1)18 (20)4·00 (2·21, 6·95)< 0·0012·80 (1·00, 7·82)0·050
Age (years)62·7(15·3)69·1(15·9)1·03 (1·02, 1·05) 1·03 (1·01, 1·05)0·001
Sex      
  M847 (57·5)44 (51)1·00 (reference) 1·00 (reference) 
  F625 (42·5)43 (49)1·32 (0·86, 2·04)0·2031·40 (0·82, 2·39)0·214
ASA fitness grade      
  < III921 (61·0)16 (18)1·00 (reference) 1·00 (reference) 
  ≥ III589 (39·0)74 (82)7·23 (4·29, 12·97)< 0·0016·16 (3·12, 12·19)< 0·001
Diabetes      
  No1296 (85·2)75 (83)1·00 (reference) 1·00 (reference) 
  Yes226 (14·8)15 (17)1·15 (0·62, 1·98)0·6390·86 (0·43, 1·73)0·681
Smoking      
  No1077 (77·3)68 (78)1·00 (reference) 1·00 (reference) 
  Yes316 (22·7)19 (22)0·95 (0·55, 1·58)0·8550·73 (0·39, 1·39)0·345
Malignancy      
  No558 (36·7)50 (56)1·00 (reference) 1·00 (reference) 
  Yes964 (63·3)40 (44)0·46 (0·30, 0·71)< 0·0010·83 (0·48, 1·44)0·503
Urgency      
  Elective837 (55·0)9 (10)1·00 (reference) 1·00 (reference) 
  Emergency685 (45·0)81 (90)11·00 (5·79, 23·68)< 0·0014·92 (2·18, 11·13)< 0·001
Time to operation (h)      
  < 6267 (18·0)18 (21)1·00 (reference) 1·00 (reference) 
  6–11111 (7·5)15 (17)2·00 (0·96, 4·12)0·0581·12 (0·46, 2·72)0·800
  12–23314 (21·2)17 (19)0·80 (0·40, 1·60)0·5290·98 (0·43, 2·19)0·952
  24–47320 (21·6)5 (6)0·23 (0·08, 0·59)0·0040·21 (0·06, 0·70)0·011
  ≥ 48470 (31·7)33 (38)1·04 (0·58, 1·92)0·8930·78 (0·39, 1·59)0·497
Laparoscopic§      
  No1115 (73·3)85 (94)1·00 (reference)  
  Yes407 (26·7)5 (6)0·16 (0·06, 0·36)< 0·001 
Perforated disease      
  No961 (63·5)32 (36)1·00 (reference) 1·00 (reference) 
  Yes552 (36·5)57 (64)3·10 (2·00, 4·89)< 0·0011·07 (0·59, 1·92)0·833
Checklist      
  No, not available197 (13·0)17 (19)1·00 (reference) 1·00 (reference) 
  No, but available92 (6·1)12 (13)1·51 (0·68, 3·27)0·2991·38 (0·46, 4·11)0·564
  Yes1223 (80·9)61 (68)0·58 (0·34, 1·04)0·0540·50 (0·22, 1·13)0·094
  Anastomosis/colostomy      
  Anastomosis1208 (79·4)48 (53)1·00 (reference) 1·00 (reference) 
  End colostomy314 (20·6)42 (47)3·37 (2·18, 5·19)< 0·0012·18 (1·23, 3·85)0·007

Values in parentheses are percentages by column unless indicated otherwise;

*

values in parentheses are 95 per cent confidence intervals and

values are mean(s.d.).

Time from presentation to index procedure.

§

Not included in multilevel model owing to low event rate in low Human Development Index (HDI) tertile (less than 1 per cent).

WHO Surgical Safety Checklist.

Table 4

Factors associated with mortality in patients undergoing left-sided colorectal resection in univariable and multilevel, multivariable logistic regression models

   Univariable analysisMultilevel analysis
 AliveDiedOdds ratio*POdds ratio*P
HDI tertile      
  High1200 (78·8)58 (64)1·00 (reference) 1·00 (reference) 
  Middle229 (15·0)14 (16)1·26 (0·67, 2·24)0·4431·60 (0·64, 3·97)0·313
  Low93 (6·1)18 (20)4·00 (2·21, 6·95)< 0·0012·80 (1·00, 7·82)0·050
Age (years)62·7(15·3)69·1(15·9)1·03 (1·02, 1·05) 1·03 (1·01, 1·05)0·001
Sex      
  M847 (57·5)44 (51)1·00 (reference) 1·00 (reference) 
  F625 (42·5)43 (49)1·32 (0·86, 2·04)0·2031·40 (0·82, 2·39)0·214
ASA fitness grade      
  < III921 (61·0)16 (18)1·00 (reference) 1·00 (reference) 
  ≥ III589 (39·0)74 (82)7·23 (4·29, 12·97)< 0·0016·16 (3·12, 12·19)< 0·001
Diabetes      
  No1296 (85·2)75 (83)1·00 (reference) 1·00 (reference) 
  Yes226 (14·8)15 (17)1·15 (0·62, 1·98)0·6390·86 (0·43, 1·73)0·681
Smoking      
  No1077 (77·3)68 (78)1·00 (reference) 1·00 (reference) 
  Yes316 (22·7)19 (22)0·95 (0·55, 1·58)0·8550·73 (0·39, 1·39)0·345
Malignancy      
  No558 (36·7)50 (56)1·00 (reference) 1·00 (reference) 
  Yes964 (63·3)40 (44)0·46 (0·30, 0·71)< 0·0010·83 (0·48, 1·44)0·503
Urgency      
  Elective837 (55·0)9 (10)1·00 (reference) 1·00 (reference) 
  Emergency685 (45·0)81 (90)11·00 (5·79, 23·68)< 0·0014·92 (2·18, 11·13)< 0·001
Time to operation (h)      
  < 6267 (18·0)18 (21)1·00 (reference) 1·00 (reference) 
  6–11111 (7·5)15 (17)2·00 (0·96, 4·12)0·0581·12 (0·46, 2·72)0·800
  12–23314 (21·2)17 (19)0·80 (0·40, 1·60)0·5290·98 (0·43, 2·19)0·952
  24–47320 (21·6)5 (6)0·23 (0·08, 0·59)0·0040·21 (0·06, 0·70)0·011
  ≥ 48470 (31·7)33 (38)1·04 (0·58, 1·92)0·8930·78 (0·39, 1·59)0·497
Laparoscopic§      
  No1115 (73·3)85 (94)1·00 (reference)  
  Yes407 (26·7)5 (6)0·16 (0·06, 0·36)< 0·001 
Perforated disease      
  No961 (63·5)32 (36)1·00 (reference) 1·00 (reference) 
  Yes552 (36·5)57 (64)3·10 (2·00, 4·89)< 0·0011·07 (0·59, 1·92)0·833
Checklist      
  No, not available197 (13·0)17 (19)1·00 (reference) 1·00 (reference) 
  No, but available92 (6·1)12 (13)1·51 (0·68, 3·27)0·2991·38 (0·46, 4·11)0·564
  Yes1223 (80·9)61 (68)0·58 (0·34, 1·04)0·0540·50 (0·22, 1·13)0·094
  Anastomosis/colostomy      
  Anastomosis1208 (79·4)48 (53)1·00 (reference) 1·00 (reference) 
  End colostomy314 (20·6)42 (47)3·37 (2·18, 5·19)< 0·0012·18 (1·23, 3·85)0·007
   Univariable analysisMultilevel analysis
 AliveDiedOdds ratio*POdds ratio*P
HDI tertile      
  High1200 (78·8)58 (64)1·00 (reference) 1·00 (reference) 
  Middle229 (15·0)14 (16)1·26 (0·67, 2·24)0·4431·60 (0·64, 3·97)0·313
  Low93 (6·1)18 (20)4·00 (2·21, 6·95)< 0·0012·80 (1·00, 7·82)0·050
Age (years)62·7(15·3)69·1(15·9)1·03 (1·02, 1·05) 1·03 (1·01, 1·05)0·001
Sex      
  M847 (57·5)44 (51)1·00 (reference) 1·00 (reference) 
  F625 (42·5)43 (49)1·32 (0·86, 2·04)0·2031·40 (0·82, 2·39)0·214
ASA fitness grade      
  < III921 (61·0)16 (18)1·00 (reference) 1·00 (reference) 
  ≥ III589 (39·0)74 (82)7·23 (4·29, 12·97)< 0·0016·16 (3·12, 12·19)< 0·001
Diabetes      
  No1296 (85·2)75 (83)1·00 (reference) 1·00 (reference) 
  Yes226 (14·8)15 (17)1·15 (0·62, 1·98)0·6390·86 (0·43, 1·73)0·681
Smoking      
  No1077 (77·3)68 (78)1·00 (reference) 1·00 (reference) 
  Yes316 (22·7)19 (22)0·95 (0·55, 1·58)0·8550·73 (0·39, 1·39)0·345
Malignancy      
  No558 (36·7)50 (56)1·00 (reference) 1·00 (reference) 
  Yes964 (63·3)40 (44)0·46 (0·30, 0·71)< 0·0010·83 (0·48, 1·44)0·503
Urgency      
  Elective837 (55·0)9 (10)1·00 (reference) 1·00 (reference) 
  Emergency685 (45·0)81 (90)11·00 (5·79, 23·68)< 0·0014·92 (2·18, 11·13)< 0·001
Time to operation (h)      
  < 6267 (18·0)18 (21)1·00 (reference) 1·00 (reference) 
  6–11111 (7·5)15 (17)2·00 (0·96, 4·12)0·0581·12 (0·46, 2·72)0·800
  12–23314 (21·2)17 (19)0·80 (0·40, 1·60)0·5290·98 (0·43, 2·19)0·952
  24–47320 (21·6)5 (6)0·23 (0·08, 0·59)0·0040·21 (0·06, 0·70)0·011
  ≥ 48470 (31·7)33 (38)1·04 (0·58, 1·92)0·8930·78 (0·39, 1·59)0·497
Laparoscopic§      
  No1115 (73·3)85 (94)1·00 (reference)  
  Yes407 (26·7)5 (6)0·16 (0·06, 0·36)< 0·001 
Perforated disease      
  No961 (63·5)32 (36)1·00 (reference) 1·00 (reference) 
  Yes552 (36·5)57 (64)3·10 (2·00, 4·89)< 0·0011·07 (0·59, 1·92)0·833
Checklist      
  No, not available197 (13·0)17 (19)1·00 (reference) 1·00 (reference) 
  No, but available92 (6·1)12 (13)1·51 (0·68, 3·27)0·2991·38 (0·46, 4·11)0·564
  Yes1223 (80·9)61 (68)0·58 (0·34, 1·04)0·0540·50 (0·22, 1·13)0·094
  Anastomosis/colostomy      
  Anastomosis1208 (79·4)48 (53)1·00 (reference) 1·00 (reference) 
  End colostomy314 (20·6)42 (47)3·37 (2·18, 5·19)< 0·0012·18 (1·23, 3·85)0·007

Values in parentheses are percentages by column unless indicated otherwise;

*

values in parentheses are 95 per cent confidence intervals and

values are mean(s.d.).

Time from presentation to index procedure.

§

Not included in multilevel model owing to low event rate in low Human Development Index (HDI) tertile (less than 1 per cent).

WHO Surgical Safety Checklist.

Discussion

This study demonstrated that end stoma rates in low-HDI countries were twice those in middle- and three times those in high-HDI countries. As each of the HDI strata included multiple hospitals of different size and nature, it suggests that variation based on income per capita may be more important than variation within countries. The difference between groups is partly explained by differences in case mix, with greater emergency presentation of both malignant and non-malignant conditions in low-HDI settings. This association persisted despite adjustment, suggesting that other factors may contribute to this variation.

Patients in LMICs were more likely to present as emergencies and to have perforated disease than patients in high-HDI settings. In part, this reflects differences in the overall disease burden, with trauma and volvulus being more common in LMICs. However, the increased frequency of emergency procedures for malignancy in LMICs may reflect barriers to accessing care and treatment for non-communicable disease in LMICs1,3. These may include limited implementation of screening programmes, inefficient referral pathways, the relatively high cost of investigations such as endoscopy3,11–12, as well as some patients having limited access to health education or a preference to seek care from traditional healers13–16. The greater burden of emergency surgery suggests that patients in LMICs may be more likely to delay a decision to seek healthcare until they have deteriorated with complicated, advanced disease. Because significant populations live more than a 2-h drive from the nearest hospital17,18, patients' conditions may deteriorate further owing to delays while identifying affordable and efficient means of transport19,20. In LMICs, once patients reach hospital, delayed and lack of appropriate investigations, staff shortages, erratic electric and water supplies, and insufficient funds to pay for care can limit and further delay surgery21. In the present study, patients in LMICs were more likely to experience significant in-hospital delays. Consistent with previous studies22,23, this was associated with end stoma formation. It should be noted in the present data, however, that in-hospital delay (48 h or more) was not associated with an increased risk of death in the mixed-effects model. This may reflect appropriate delay of surgical intervention (such as for preoperative optimization of an obstructing cancer) and appropriate rationalization of resources (the most unwell patients were prioritized for early access to theatre resources) across included hospitals. The three stages of delay in accessing acute care, in making a decision to travel to hospital, in travelling to hospital, and in hospital24, all contribute to patients in LMICs being more likely to present acutely unwell with complicated disease that makes primary restorative surgery challenging, and influencing the decision whether primary anastomosis or end colostomy is appropriate25.

Differences in training and provision of specialist colorectal surgery, and lack of available or affordable equipment for technically difficult anastomoses, could also affect stoma rates. With fewer patients presenting with operable colorectal cancer in many low-HDI countries3,12 and fewer formal training opportunities, access to subspecialist colorectal services is limited3,26–27. High baseline mortality rates2, inadequate provision of critical care support28,29 and insufficient medicolegal protection30 may also promote risk-averse practices. Stapling devices may be unaffordable for both patient and provider in many LMICs, meaning that only selected patients have access to these techniques31. Similarly, although laparoscopic colorectal resection was performed in middle-HDI settings, it was uncommon. Lack of affordable laparoscopic equipment, variable provision of training and hospital-level difficulties, such as a reliable electrical supply, remain barriers to minimal access surgery in LMIC settings32, despite potential for patient benefit33,34.

The high mortality rate for both elective and emergency surgery reported in this study supports previous findings that patients have a higher risk of death following surgery in low-HDI settings which cannot be accounted for by case mix alone2,35. The present analysis showed that patients undergoing end stoma formation were at increased risk of death. Despite adjustment, this finding could represent a surrogate marker of disease severity where the highest-risk patients are being selected to receive a stoma. In the present study, it was not possible to measure physiological markers of disease severity beyond ASA classification (such as hypotension, tachycardia, high lactate level or an end-organ perfusion deficit) that could influence surgical decision-making and outcomes.

This study has important limitations that could affect its generalizability. As it included a relatively low mean number of patients per centre in a ‘snapshot’ methodology, no analysis was performed at a per-centre or per-country level. Although only one-quarter of patients in the data set were from LMICs, sites across 30 countries contributed data, bolstering external generalizability across LMIC settings. Data were collected across all HDI tertiles in both emergency (GlobalSurg-1 and -2) and elective (GlobalSurg-2) settings, and are relevant to both planned and unplanned left-sided colorectal resections, but numbers in some groups (such as elective operations for cancer in low-HDI settings) were small. Further validation of these findings is therefore required in future work. Although there were no centre-level exclusion criteria for case volume or infrastructure, a sampling bias is likely to exist, wherein the best resourced and/or academically affiliated centres within LMICs were more likely to access the study protocol and provide patient data than those in remote and rural settings. This may have led to an underestimate of the true rate of end stoma formation within LMICs.

Reported end colostomy rates have varied from 0 to as high as 74 per cent25,36–39 in groups including emergency surgery39, late presentations of cancer25, complications of infectious disease38 and traumatic injury36. The collaborative methodology in the present study enabled clinicians to enter data into a secure online platform contemporaneously alongside their clinical practice, in accordance with a prespecified protocol. This led to high levels of data accuracy and completeness40 and has provided the basis on which further studies can be developed to examine other factors that influence outcomes in different settings.

Acknowledgements

This paper reports the results of two preregistered studies (ClinicalTrials.gov; NCT02179112 and NCT02662231). To minimize the possibility of unintentionally sharing information that can be used to reidentify private information, a subset of the summary data generated for this study are available in an online visualization application that can be accessed at http://ssi.globalsurg.org40.

Organizations assisting in dissemination and/or translation: Asian Medical Students' Association; Association of Surgeons in Training; College of Surgeons of East, Central and Southern Africa; Cutting Edge Manipal; Egyptian Medical Student Research Association; International Collaboration for Essential Surgery; International Federation of Medical Student Associations; Italian Society of Colorectal Surgery; Lifebox Foundation; School of Surgery; Student Audit and Research in Surgery; The Electives Network; United Kingdom National Research Collaborative; World Society of Emergency Surgery; and World Surgical Association.

This study was funded by Department For International Development–Medical Research Council–Wellcome Trust Joint Global Health Trial Development grant (MR/N022114/1) and a National Institute of Health Research (NIHR) Global Health Research Unit Grant (NIHR 16/136/79). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health.

 

Patient viewpoint

This study reveals global variation in end colostomy rates after left-sided colorectal resection; stoma rates in low-HDI countries were twice those in middle- and three times those in high-HDI countries.

Awakening after surgery with a colostomy will have been a traumatic experience for all 362 patients. I wish we could ask everyone who still survives today some honest questions about their quality of life since. I imagine those in high-HDI countries will have adapted better to their changed bodies and altered selves than their low-HDI counterparts.

In high-HDI England my own stoma is easy to accommodate thanks to freely accessible healthcare, uninterrupted supplies of decent ileostomy bags, sanitation, plentiful water, an angel of a specialist stoma nurse, and legal protection from societal or workplace discrimination: I am fortunate to enjoy a lovely life as a ‘Bag Lady’.

The absence of such enabling factors can, however, make having a stoma far more burdensome in low-HDI countries. Financial ruin, inability to resume usual daily activities, societal rejection, family/community shame, and becoming unemployable and unmarriageable are, sadly, common sequelae. Indeed, my East African-born parents insist that had I not been ‘Made in Britain’ long after they relocated to England, I would have suffered ‘intolerable strife or loss of life’.

There is a real need to reduce avoidable stoma formation globally. This need is most pressing in low-HDI countries where physical, psychological, economic, educational and social challenges are magnified. The insurmountable obstacles they may face in low-HDI settings can lead patients to question whether surviving surgery is in fact the superior of the two possible outcomes. Thus, although surgeons in restricted-resource settings may have good reason to fear the consequences of anastomotic leaks, patients may have greater reason to fear the lifelong consequences of a stoma.

Ms Azmina Verjee

GlobalSurg UK Patient Representative

References

1

Sullivan
 
R
,
Alatise
 
OI
,
Anderson
 
BO
,
Audisio
 
R
,
Autier
 
P
,
Aggarwal
 
A
 et al. .
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
.
Lancet Oncol
 
2015
;
16
:
1193
1224
.

2

GlobalSurg Collaborative
.
Mortality of emergency abdominal surgery in high-, middle- and low-income countries
.
Br J Surg
 
2016
;
103
:
971
988
.

3

Arnold
 
M
,
Sierra
 
MS
,
Laversanne
 
M
,
Soerjomataram
 
I
,
Jemal
 
A
,
Bray
 
F
.
Global patterns and trends in colorectal cancer incidence and mortality
.
Gut
 
2017
;
66
:
683
691
.

4

Morris
 
E
,
Quirke
 
P
,
Thomas
 
JD
,
Fairley
 
L
,
Cottier
 
B
,
Forman
 
D
 
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?
 
Gut
 
2008
;
57
:
1690
1697
.

5

Thyø
 
A
,
Emmertsen
 
KJ
,
Pinkney
 
TD
,
Christensen
 
P
,
Laurberg
 
S
 
The colostomy impact score: development and validation of a patient reported outcome measure for rectal cancer patients with a permanent colostomy. A population-based study
.
Colorectal Dis
 
2017
;
19
:
O25
O33
.

6

Ameh
 
EA
,
Mshelbwala
 
PM
,
Sabiu
 
L
,
Chirdan
 
LB
.
Colostomy in children – an evaluation of acceptance among mothers and caregivers in a developing country
.
S Afr J Surg
 
2006
;
44
:
138
139
.

7

Shrime
 
MG
,
Dare
 
AJ
,
Alkire
 
BC
,
O'Neill
 
K
,
Meara
 
JG
.
Catastrophic expenditure to pay for surgery worldwide: a modelling study
.
Lancet Glob Health
 
2015
;
3
(
Suppl 2
):
S38
S44
.

8

GlobalSurg Collaborative
.
Determining the worldwide epidemiology of surgical site infections after gastrointestinal resection surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 2)
.
BMJ Open
 
2017
;
7
:
e012150
.

9

von Elm
 
E
,
Altman
 
DG
,
Egger
 
M
,
Pocock
 
SJ
,
Gøtzsche
 
PC
,
Vandenbroucke
 
JP
;
STROBE Initiative
.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
.
PLoS Med
 
2007
;
4
:
e296
.

10

Haynes
 
AB
,
Weiser
 
TG
,
Berry
 
WR
,
Lipsitz
 
SR
,
Breizat
 
AH
,
Dellinger
 
EP
 et al. ;
Safe Surgery Saves Lives Study Group
.
A surgical safety checklist to reduce morbidity and mortality in a global population
.
N Engl J Med
 
2009
;
360
:
491
499
.

11

Ahmed
 
F
.
Barriers to colorectal cancer screening in the developing world: the view from Pakistan
.
World J Gastrointest Pharmacol Ther
 
2013
;
4
:
83
85
.

12

Lambert
 
R
,
Sauvaget
 
C
,
Sankaranarayanan
 
R
.
Mass screening for colorectal cancer is not justified in most developing countries
.
Int J Cancer
 
2009
;
125
:
253
256
.

13

Langenbach
 
MR
,
Schmidt
 
J
,
Neumann
 
J
,
Zirngibl
 
H
.
Delay in treatment of colorectal cancer: multifactorial problem
.
World J Surg
 
2003
;
27
:
304
308
.

14

Irfan
 
FB
,
Irfan
 
BB
,
Spiegel
 
DA
.
Barriers to accessing surgical care in Pakistan: healthcare barrier model and quantitative systematic review
.
J Surg Res
 
2012
;
176
:
84
94
.

15

Barker
 
RD
,
Millard
 
FJ
,
Malatsi
 
J
,
Mkoana
 
L
,
Ngoatwana
 
T
,
Agarawal
 
S
 et al. .
Traditional healers, treatment delay, performance status and death from TB in rural South Africa
.
Int J Tuberc Lung Dis
 
2006
;
10
:
670
675
.

16

Okeke
 
TA
,
Okafor
 
HU
,
Uzochukwu
 
BS
.
Traditional healers in Nigeria: perception of cause, treatment and referral practices for severe malaria
.
J Biosoc Sci
 
2006
;
38
:
491
500
.

17

Raykar
 
NP
,
Bowder
 
AN
,
Liu
 
C
,
Vega
 
M
,
Kim
 
JH
,
Boye
 
G
 et al. .
Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries
.
Lancet
 
2015
;
385
(
Suppl 2
):
S16
.

18

Ouma
 
PO
,
Maina
 
J
,
Thuranira
 
PN
,
Macharia
 
PM
,
Alegana
 
VA
,
English
 
M
 et al. .
Access to emergency hospital care provided by the public sector in sub-Saharan Africa in 2015: a geocoded inventory and spatial analysis
.
Lancet Glob Health
 
2018
;
6
:
e342
e350
.

19

Grimes
 
CE
,
Bowman
 
KG
,
Dodgion
 
CM
,
Lavy
 
CB
.
Systematic review of barriers to surgical care in low-income and middle-income countries
.
World J Surg
 
2011
;
35
:
941
950
.

20

Wilson
 
A
,
Hillman
 
S
,
Rosato
 
M
,
Skelton
 
J
,
Costello
 
A
,
Hussein
 
J
 et al. .
A systematic review and thematic synthesis of qualitative studies on maternal emergency transport in low- and middle-income countries
.
Int J Gynaecol Obstet
 
2013
;
122
:
192
201
.

21

Adamu
 
A
,
Maigatari
 
M
,
Lawal
 
K
,
Iliyasu
 
M
 
Waiting time for emergency abdominal surgery in Zaria, Nigeria
.
Afr Health Sci
 
2010
;
10
:
46
53
.

22

Ong
 
M
,
Guang
 
TY
,
Yang
 
TK
.
Impact of surgical delay on outcomes in elderly patients undergoing emergency surgery: a single center experience
.
World J Gastrointest Surg
 
2015
;
7
:
208
213
.

23

Khan
 
S
,
Zafar
 
H
,
Zafar
 
SN
,
Haroon
 
N
.
Inter-facility transfer of surgical emergencies in a developing country: effects on management and surgical outcomes
.
World J Surg
 
2014
;
38
:
281
286
.

24

Thaddeus
 
S
,
Maine
 
D
.
Too far to walk: maternal mortality in context
.
Soc Sci Med
 
1994
;
38
:
1091
1110
.

25

Saidi
 
H
,
Nyaim
 
EO
,
Githaiga
 
JW
,
Karuri
 
D
.
CRC surgery trends in Kenya, 1993-2005
.
World J Surg
 
2008
;
32
:
217
223
.

26

Hoyler
 
M
,
Hagander
 
L
,
Gillies
 
R
,
Riviello
 
R
,
Chu
 
K
,
Bergström
 
S
 et al. .
Surgical care by non-surgeons in low-income and middle-income countries: a systematic review
.
Lancet
 
2015
;
385
(
Suppl 2
):
S42
.

27

Federspiel
 
F
,
Mukhopadhyay
 
S
,
Milsom
 
P
,
Scott
 
JW
,
Riesel
 
JN
,
Meara
 
JG
.
Global surgical and anaesthetic task shifting: a systematic literature review and survey
.
Lancet
 
2015
;
385
(
Suppl 2
):
S46
.

28

Firth
 
P
,
Ttendo
 
S
.
Intensive care in low-income countries – a critical need
.
N Engl J Med
 
2012
;
367
:
1974
1976
.

29

Adhikari
 
NK
,
Fowler
 
RA
,
Bhagwanjee
 
S
,
Rubenfeld
 
GD
.
Critical care and the global burden of critical illness in adults
.
Lancet
 
2010
;
376
:
1339
1346
.

30

Gordhan
 
CG
,
Anandalwar
 
SP
,
Son
 
J
,
Ninan
 
GK
,
Chokshi
 
RJ
.
Malpractice in colorectal surgery: a review of 122 medicolegal cases
.
J Surg Res
 
2015
;
199
:
351
356
.

31

Adisa
 
AO
,
Olasehinde
 
O
,
Arowolo
 
OA
,
Alatise
 
OI
,
Agbakwuru
 
EA
.
Early experience with stapled gastrointestinal anastomoses in a Nigerian hospital
.
Niger J Surg
 
2015
;
21
:
140
142
.

32

Ismaila
 
BO
,
Shuaibu
 
SI
,
Ale
 
AA
.
Laparoscopic surgery in a Nigerian teaching hospital for 1 year: challenges and effect on outcomes
.
Niger J Med
 
2013
;
22
:
134
137
.

33

van der Pas
 
MH
,
Haglind
 
E
,
Cuesta
 
MA
,
Fürst
 
A
,
Lacy
 
AM
,
Hop
 
WC
 et al. ;
COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group
.
Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial
.
Lancet Oncol
 
2013
;
14
:
210
218
.

34

COLOR Study Group
.
COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer
.
Dig Surg
 
2000
;
17
:
617
622
.

35

Biccard
 
BM
,
Madiba
 
TE
,
Kluyts
 
HL
,
Munlemvo
 
DM
,
Madzimbamuto
 
FD
,
Basenero
 
A
 et al. ;
African Surgical Outcomes Study (ASOS) investigators
.
Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study
.
Lancet
 
2018
;
391
:
1589
1598
.

36

Angelici
 
AM
,
Montesano
 
G
,
Nasti
 
AG
,
Palumbo
 
P
,
Vietri
 
F
 
Treatment of gunshot wounds to the colon: experience in a rural hospital during the civil war in Somalia
.
Ann Ital Chir
 
2004
;
75
:
461
464
.

37

Asuquo
 
ME
,
Bassey
 
OO
,
Etiuma
 
AU
,
Ugare
 
G
,
Ngim
 
O
.
A prospective study of penetrating abdominal trauma at the University of Calabar Teaching Hospital, Calabar, Southern Nigeria
.
Eur J Trauma Emerg Surg
 
2009
;
35
:
277
,
280
.

38

Athié-Gutiérrez
 
C
,
Rodea-Rosas
 
H
,
Guízar-Bermúdez
 
C
,
Alcántara
 
A
,
Montalvo-Javé
 
EE
.
Evolution of surgical treatment of amebiasis-associated colon perforation
.
J Gastrointest Surg
 
2010
;
14
:
82
87
.

39

Chalya
 
PL
,
Mabula
 
JB
.
Sigmoid volvulus and ileo-sigmoid knotting: a five-year experience at a tertiary care hospital in Tanzania
.
World J Emerg Surg
 
2015
;
10
:
10
.

40

GlobalSurg Collaborative
.
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
.
Lancet Infect Dis
 
2018
;
18
:
516
525
.

Author notes

Members of the GlobalSurg Collaborative are collaborators in this study and are listed in Appendix S1 (supporting information)

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]